当前位置:首页 > 股票大全 > 未名医药 002581 财务分析

未名医药财务分析

整理编辑：168股票行情网：www.gphq168.com    数据来源：互联网 经供参考

未名医药(002581)利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入83,804,783.29429,790,105.06338,346,310.25209,166,285.01
营业总成本106,361,412.35610,716,591.63430,315,379.45283,687,805.59
营业利润-27,947,839.97-293,351,196.844,625,168.95-50,456,579.84
利润总额-26,847,045.89-313,249,951.442,686,285.45-51,417,931.27
净利润-27,055,340.81-322,135,112.2738,528,504.57-50,853,180.78
其他综合收益----
综合收益总额-27,055,340.81-322,135,112.2738,528,504.57-50,853,180.78
未名医药(002581)资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计508,532,507.81496,708,183.14676,897,541.26444,204,433.55
非流动资产合计1,747,414,709.821,840,429,765.892,122,168,550.932,305,381,737.87
资产总计2,255,947,217.632,337,137,949.032,799,066,092.192,749,586,171.42
流动负债合计75,844,964.49133,608,055.33259,738,609.13305,576,584.87
非流动负债合计27,032,180.6729,803,542.422,940,305.7323,945,535.17
负债合计102,877,145.16163,411,597.73282,678,914.86329,522,120.04
归属于母公司股东权益合计2,047,162,710.742,068,467,729.912,412,636,572.642,322,224,512.51
股东权益合计2,153,070,072.472,173,726,351.32,516,387,177.332,420,064,051.38
负债和股东权益合计2,255,947,217.632,337,137,949.032,799,066,092.192,749,586,171.42
未名医药(002581)现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计103,266,237.28562,943,291.09382,364,927.25197,682,588.45
经营活动现金流出小计118,467,212.95599,449,495.29380,489,702.15255,527,572.01
经营活动产生的现金流量净额-15,200,975.67-36,506,204.21,875,225.1-57,844,983.56
投资活动现金流入小计78,870,135.54260,968,001.15258,826,588.154,289,588.15
投资活动现金流出小计122,925.074,318,774.9629,230,422.6728,819,407.47
投资活动产生的现金流量净额78,747,210.47256,649,226.19229,596,165.48-24,529,819.32
筹资活动现金流入小计-13,837,59110,000,0008,229,550
筹资活动现金流出小计93,362.37224,978,816.7167,221,792.7425,542,642.56
筹资活动产生的现金流量净额-93,362.37-211,141,225.71-57,221,792.74-17,313,092.56
汇率变动对现金及现金等价物的影响131.63-453.9200
现金及现金等价物净增加额63,453,004.069,001,342.36174,249,597.84-99,687,895.44
期末现金及现金等价物余额215,248,425.84151,795,421.78317,043,677.2643,106,183.98
未名医药002581相关数据
今日股市大盘指数